All trenbolone acetate 100 drugs are taken twice a day for 7 days; • prevention of relapse of peptic ulcers associated with pylori Helicobacter – esomeprazole 20 mg, 1 g of amoxicillin and 500 mg of clarithromycin. All drugs are taken twice a day for 7 days.
Subsequently, the dose is adjusted individually, the duration of treatment is determined by the clinical picture of the disease. Any application experience in the range from 80 mg to 120 mg per day of esomeprazole. In applying the drug at a dose greater than 80 mg is necessary to divide the drug twice a day. Renal insufficiency: correction dose is not required. Hepatic impairment:in mild to moderate hepatic impairment dose adjustment is required. For patients with severe hepatic impairment should not exceed the maximum daily dose – 20 mg. Elderly patients: correction dose is not required.
The introduction of the drug by gavage In appointing the drug by gavage 1. Place the tablet in a syringe and fill the syringe with 25 ml water and approximately 5 mL air. Some probes may require dilution of the drug in 50 ml of drinking water to prevent clogging of the probe beads tablets. 2. Immediately shake the syringe for approximately two minutes to dissolve the tablets. 3. Keep the syringe tip up and check that the tip has not clogged. 4. Enter the syringe tip into the probe, while still holding it upward. 5. Shake trenbolone acetate 100 the syringe tip and turn it down. 5.10 ml immediately enter into the probe-dissolved preparation. After the introduction of the syringe return to its previous position and shake (the syringe must be held the tip up to avoid clogging of the tip). 6. Turn the syringe tip down and enter another 5-10 ml of the drug in the probe. Repeat this procedure until the syringe is not empty. 7. In the case of the remainder of the drug in the form of sediment in the syringe, fill the syringe with 25 ml of water and 5 mL of air and repeat the operations described in paragraphs 5 and 6. For some probes for this purpose may need 50 ml of drinking water.
Violations of the blood and lymphatic system Rare: leukopenia, thrombocytopenia; very rare: agranulocytosis, pancytopenia. Disorders of the nervous system and sensory organs often: headache; rare: insomnia , dizziness, paresthesia, drowsiness, blurred vision, rare: agitation, confusion, depression, very rare: aggression, hallucinations. Violations of the gastrointestinal tract often: abdominal pain, constipation, diarrhea, flatulence, nausea / vomiting, infrequently : dry mouth; rare: taste disturbance, stomatitis, candidiasis of the digestive tract, the frequency is not known: microscopic colitis (confirmed histologically). Violations of the liver and biliary tract uncommon: increased activity of “liver” transaminases, rare: hepatitis with or without jaundice, very rare: hepatic failure, encephalopathy in patients imeyushih history of liver disease. disorders of the respiratory system, organs, thoracic and mediastinal disorders rare: bronchospasm. Violations of the skin and subcutaneous tissue disorders uncommon: dermatitis, pruritus, rash, urticaria rare: alopecia , photosensitivity, very rarely: erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, the frequency is unknown: subacute cutaneous lupus erythematosus. Violations of the musculoskeletal and connective tissue uncommon: hip fractures, wrist bones, vertebrae; rare: arthralgia, myalgia; very rare: muscular weakness. Violations of the kidney and urinary tract infections are very rare: interstitial nephritis; some patients have reported the development of renal failure. Violations of the genital and breast very rarely . gynecomastia Violations by the immune system rare: hypersensitivity reactions trenbolone acetate 100 (eg, fever, angioedema and anaphylactic reaction / anaphylactic shock). Violations of the exchange substances and supply rare: peripheral edema; rare: hyponatremia; very rare: hypomagnesemia may be associated with hypokalemia; severe hypomagnesaemia can correlate with hypocalcaemia. General disorders and administration site in rarely malaise, increased sweating.